Evidence map›Paper›PMID 42463888›Full record

ArticleNature genetics2026

Pioneer transcription factors direct tissue-specific cohesin chromatin entry and three-dimensional genome organization.

Song Wang, Xianglin Zhang, Tianwei Jia, Wenzheng Wang, Xiaoyu Liu, Hui Lin, Haoran Pan, Jinyi Zhang, Dongqing Li, Lin Zhang and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Song Wang *Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.ORCID http://orcid.org/0000-0003-0326-686X
Xianglin Zhang *Department of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Tianwei Jia *Department of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Wenzheng Wang *State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Shandong Engineering & Technology Research Center for Tumor Marker Detection, Second Qilu Hospital of Shandong University, Jinan, China.
Xiaoyu Liu *Department of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Hui LinDepartment of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Haoran PanDepartment of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Jinyi ZhangDepartment of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Dongqing LiDepartment of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.ORCID http://orcid.org/0009-0005-6982-8484
Lin ZhangDepartment of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Tianli ZhangDepartment of Gynecology, Second Qilu Hospital of Shandong University, Jinan, China.
Ping GuoDepartment of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China.
Jing LiDepartment of Precision Medicine, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.ORCID http://orcid.org/0000-0002-7973-3930
Yunshan WangDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Haojie HuangInstitute of Urologic Science and Technology, Zhejiang University School of Medicine, First Affiliated Hospital of Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0003-2751-6413
Zhao WeiDepartment of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China. weizhao@sdu.edu.cn.ORCID http://orcid.org/0000-0003-2825-2667
Housheng Hansen HePrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Hansenhe@uhnresearch.ca.ORCID http://orcid.org/0000-0003-2898-3363
Haiyang GuoDepartment of Clinical Laboratory, Second Qilu Hospital of Shandong University, Jinan, China. haiyang.guo@email.sdu.edu.cn.ORCID http://orcid.org/0000-0001-5503-6922

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 142246National Natural Science Foundation of China (National Science Foundation of China) 32402860National Natural Science Foundation of China (National Science Foundation of China) 32570639National Natural Science Foundation of China (National Science Foundation of China) 81901421National Natural Science Foundation of China (National Science Foundation of China) 82173052Taishan Scholar Foundation of Shandong Province NO.tstp20250753Taishan Scholar Foundation of Shandong Province NO.tstp20250755
6 · The paper itself

Abstract

Cohesin organizes three-dimensional genome architecture by extruding DNA loops, but the mechanisms specifying its chromatin entry sites remain unclear. Here we show that the cohesin loader NIPBL is prepositioned at highly tissue-specific sites, largely distinct from the broadly conserved binding profiles of CTCF and cohesin. Motif and chromatin immunoprecipitation-sequencing analyses identify pioneer transcription factors, particularly FOXA1, as key mediators of the tissue-specific NIPBL recruitment. FOXA1 directs NIPBL to intratopologically associating domain (TAD) regions, enabling symmetric loop extrusion, whereas ETS factors guide NIPBL to TAD boundaries, supporting asymmetric extrusion. FOXA1 depletion disrupts NIPBL binding and impairs intra-TAD loops selectively, whereas NIPBL loss reduces both intra-TAD and boundary-to-boundary interactions. In prostate cancer, the recurrent FOXA1 R219S mutation redirects FOXA1-NIPBL to TAD boundaries, fostering a more insulated and aggressive genome. These findings reveal how pioneer factors orchestrate cohesin loading to shape tissue-specific three-dimensional genome organization and how this mechanism is co-opted in cancer.

Indexed as

Cell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneGenomeHepatocyte Nuclear Factor 3-alphaTranscription FactorsAnimalsCCCTC-Binding FactorCohesinsHumansMaleOrgan SpecificityProtein BindingCCCTC-Binding FactorCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCohesinsFOXA1 protein, humanHepatocyte Nuclear Factor 3-alphaTranscription Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.